Signal #129194 · SEC 8-K

$RPRX SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $RPRX filing catalyst

Why did $RPRX trigger an AI stock catalyst alert?

$RPRX triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Royalty Pharma Reports Q3 2026 Portfolio Receipts Up 9% to $890M, Raises FY Guidance. Key points: - Q3 2026 Portfolio Receipts rose 9% year-over-year to $890M with operating cash flow of $686M. - Full-year 2026 Portfolio Receipts guidance increased to $3,500M–$3,550M. - Growth driven by Evrysdi (+38%) and Voranigo (+65%), offsetting slight Trelegy contraction.

How did $RPRX stock react after the SEC filing?

After the SEC 8-K for $RPRX, observed market reaction: T0 price $66.40. Past moves do not guarantee future results.

Where can I get real-time $RPRX SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $RPRX via Telegram and the VIP Web Terminal from €10/month.

$RPRX

$RPRX – Royalty Pharma Reports Q3 2026 Portfolio Receipts Up 9% to $890M, Raises FY Guidance

Royalty Pharma plc

2026-11-04 00:00:00 UTC · SEC 8-K · All $RPRX

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)

Q3 2026 Portfolio Receipts rose 9% year-over-year to $890M with operating cash flow of $686M.
Full-year 2026 Portfolio Receipts guidance increased to $3,500M–$3,550M.
Growth driven by Evrysdi (+38%) and Voranigo (+65%), offsetting slight Trelegy contraction.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →